|
Volumn 80, Issue 3, 2001, Pages 251-260
|
A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis
|
Author keywords
American tegumentary leishmaniasis; Immunogenicity; Leishmania amazonensis; Leishmanin skin test; Vaccine
|
Indexed keywords
CYTOKINE;
GAMMA INTERFERON;
INTERLEUKIN 2;
LEISHMANIA VACCINE;
IMMUNE RESPONSE;
LEISHMANIASIS;
VACCINATION;
ADOLESCENT;
ADULT;
ARTICLE;
CELL CULTURE;
CELL PROLIFERATION;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SCREENING;
FEMALE;
HUMAN;
HUMAN CELL;
IMMUNOGENICITY;
LEISHMANIA;
LEISHMANIASIS;
MALE;
MONONUCLEAR CELL;
NONHUMAN;
NORMAL HUMAN;
PROMASTIGOTE;
RANDOMIZED CONTROLLED TRIAL;
SKIN TEST;
ADOLESCENT;
ADULT;
ANIMALS;
ANTIGENS, PROTOZOAN;
CELLS, CULTURED;
CYTOKINES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
LEISHMANIA;
LEISHMANIASIS, CUTANEOUS;
LEUKOCYTES, MONONUCLEAR;
LYMPHOCYTE ACTIVATION;
MALE;
MIDDLE AGED;
PROTOZOAN VACCINES;
SKIN TESTS;
VACCINATION;
SOUTH AMERICA;
LEISHMANIA AMAZONENSIS;
|
EID: 0035930387
PISSN: 0001706X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0001-706X(01)00181-4 Document Type: Article |
Times cited : (31)
|
References (28)
|